circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA
Authors:
Open Access
- 2 June 2022
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 41 (1) , 1-19
Abstract
Background: Circular RNA (circRNA) is a novel class noncoding RNA (ncRNA) that plays a critical role in various cancers, including prostate cancer (PCa). However, the clinical significance, biological function, and molecular mechanisms of circRNAs in prostate cancer remain to be elucidated.Methods: A circRNA array was performed to identified the differentially expressed circRNAs. circPDE5A was identified as a novel circRNA which downregulated in clinical samples. Functionally, the in vitro and in vivo assays were applied to explore the role of circPDE5A in PCa metastasis. Mechanistically, the interaction between circPDE5A and WTAP was verified using RNA pulldown followed by mass spectrometry, RNA Immunoprecipitation (RIP) assays. m6A methylated RNA immunoprecipitation sequencing (MeRIP-seq) was then used to identified the downstream target of circPDE5A. Chromatin immunoprecipitation assay (ChIP) and dual-luciferase reporter assay were used to identified transcriptional factor which regulated circPDE5A expression.Results: circPDE5A was identified downregulated in PCa tissues compared to adjacent normal tissue and was negatively correlated with gleason score of PCa patients. circPDE5A inhibits PCa cells migration and invasion both in vitro and in vivo. circPDE5A blocks the WTAP-dependent N6-methyladenisine (m6A) methylation of eukaryotic translation initiation factor 3c (EIF3C) mRNA by forming the circPDE5A-WTAP complex, and finally disrupts the translation of EIF3C. Moreover, the circPDE5A-dependent decrease in EIF3C expression inactivates the MAPK pathway and then restrains PCa progression.Conclusions: Our findings demonstrate that FOXO4-mediated upregulation of circPDE5A controls PCa metastasis via the circPDE5A-WTAP-EIF3C-MAPK signaling pathway and could serve as a potential therapeutic targer for PCa.Keywords
Funding Information
- National Natural Science Foundation of China (81672520, 81870484, 81773789,82072809)
This publication has 52 references indexed in Scilit:
- Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) PathwayMedical Science Monitor, 2017
- Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAsNature Communications, 2016
- Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2Nucleic Acids Research, 2016
- Foxo3 activity promoted by non-coding effects of circular RNA and Foxo3 pseudogene in the inhibition of tumor growth and angiogenesisOncogene, 2015
- Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human gliomaOncology Reports, 2015
- A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate CancerPLOS ONE, 2014
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferaseCell Research, 2014
- eIF3c: A potential therapeutic target for cancerCancer Letters, 2013
- Noncoding RNAs and CancerCell, 2013
- Non-coding RNAs in human diseaseNature Reviews Genetics, 2011